U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07334886) titled 'A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)' on Dec. 31, 2025.
Brief Summary: The goal of this study is to learn how [14C]ulonivirine moves through a healthy person's body over time. Researchers will study how [14C]ulonivirine is absorbed by the body, broken down by the body, and how it leaves the body.
Study Start Date: Sept. 17, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: [14C]Ulonivirine
Oral Solution
Recruitment Status: COMPLETED
Sponsor: Merck Sharp & Dohme LLC
Disclaimer: Curated by HT Syndication....